Audible会員プラン登録で、20万以上の対象タイトルが聴き放題。

プレビューの再生
  • Drugs and the FDA

  • Safety, Efficacy, and the Public's Trust
  • 著者: Mikkael A. Sekeres
  • ナレーター: Mike Lenz
  • 再生時間: 8 時間 40 分

Audible会員プラン 無料体験

会員は、20万以上の対象作品が聴き放題
アプリならオフライン再生可能
プロの声優や俳優の朗読も楽しめる
Audibleでしか聴けない本やポッドキャストも多数
無料体験終了後は月会費1,500円。いつでも退会できます

Drugs and the FDA

著者: Mikkael A. Sekeres
ナレーター: Mike Lenz
30日間の無料体験を試す

無料体験終了後は月額¥1,500。いつでも退会できます。

¥2,600 で購入

¥2,600 で購入

下4桁がのクレジットカードで支払う
ボタンを押すと、Audibleの利用規約およびAmazonのプライバシー規約同意したものとみなされます。支払方法および返品等についてはこちら

あらすじ・解説

Food and Drug Administration approval for COVID-19 vaccines and the controversial Alzheimer's drug Aduhelm made headlines, but few of us know much about how the agency does its work. Why is the FDA the ultimate United States authority on a drug's safety and efficacy? In Drugs and the FDA, Mikkael Sekeres—a leading oncologist and former chair of the FDA's cancer drug advisory committee—tells the story of how the FDA became the most trusted regulatory agency in the world. It took a series of tragedies and health crises, as well as patient advocacy, for the government to take responsibility for ensuring the efficacy and safety of drugs and medical devices.

Before the FDA existed, drug makers could hawk any potion, claim treatment of any ailment, and make any promise on a label. But then, throughout the twentieth century, the government was forced to take action when children were poisoned by contaminated diphtheria and smallpox vaccines, an early antibiotic contained antifreeze, a drug prescribed for morning sickness in pregnancy caused babies to be born disfigured, and access to AIDS drugs was limited to a few clinical trials while thousands died. Sekeres describes all these events against the backdrop of the contentious 2011 hearings on the breast cancer drug Avastin, in which he participated as a panel member.

©2022 Mikkael A. Sekeres (P)2023 Tantor

Drugs and the FDAに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。